Published in PLoS One on January 18, 2010
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS One (2012) 3.49
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol (2010) 1.89
Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res (2013) 1.78
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med (2012) 1.71
Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63
Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper. World Allergy Organ J (2012) 1.60
Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol (2013) 1.35
Oral and airway microbiota in HIV-infected pneumonia patients. J Clin Microbiol (2012) 1.30
Characterization of coastal urban watershed bacterial communities leads to alternative community-based indicators. PLoS One (2010) 1.24
Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J (2012) 1.10
Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J (2015) 0.98
Effect of barrier microbes on organ-based inflammation. J Allergy Clin Immunol (2013) 0.97
Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial. PLoS One (2014) 0.96
Composition of the gut microbiota modulates the severity of malaria. Proc Natl Acad Sci U S A (2016) 0.92
Application of phylogenetic microarrays to interrogation of human microbiota. FEMS Microbiol Ecol (2011) 0.88
Microbial diversity in the era of omic technologies. Biomed Res Int (2013) 0.87
Relative cost-effectiveness of an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Italy. Clinicoecon Outcomes Res (2015) 0.83
Probiotic manipulation of the gastrointestinal microbiota. Gut Microbes (2010) 0.82
The Airway Microbiome at Birth. Sci Rep (2016) 0.79
Reanalysis and simulation suggest a phylogenetic microarray does not accurately profile microbial communities. PLoS One (2012) 0.79
Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics. PLoS One (2015) 0.78
Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens. Ann Neurol (2016) 0.78
Biome engineering-2020. Microb Biotechnol (2016) 0.76
Intestinal Bacterial Colonization in the First 2 Weeks of Life of Nigerian Neonates Using Standard Culture Methods. Front Pediatr (2016) 0.75
Recent Understandings of Pet Allergies. F1000Res (2016) 0.75
Nasopharyngeal microbiota composition of children is related to the frequency of upper respiratory infection and acute sinusitis. Microbiome (2016) 0.75
Lactobacillus rhamnosus GG modulates innate signaling pathway and cytokine responses to rotavirus vaccine in intestinal mononuclear cells of gnotobiotic pigs transplanted with human gut microbiota. BMC Microbiol (2016) 0.75
Bacterial community structure transformed after thermophilically composting human waste in Haiti. PLoS One (2017) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
Diversity of the human intestinal microbial flora. Science (2005) 49.64
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
Development of the human infant intestinal microbiota. PLoS Biol (2007) 18.91
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57
Hay fever, hygiene, and household size. BMJ (1989) 15.94
FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol (2009) 15.15
Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics (2006) 14.96
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (2006) 9.95
Picante: R tools for integrating phylogenies and ecology. Bioinformatics (2010) 9.84
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med (2000) 5.93
High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol (2007) 4.81
Urban aerosols harbor diverse and dynamic bacterial populations. Proc Natl Acad Sci U S A (2006) 4.62
Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet (2000) 4.19
Microbial diversity of hydrothermal sediments in the Guaymas Basin: evidence for anaerobic methanotrophic communities. Appl Environ Microbiol (2002) 4.14
Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation. Appl Environ Microbiol (2006) 4.09
Initial community evenness favours functionality under selective stress. Nature (2009) 4.07
Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun (2008) 3.68
Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet (2003) 2.92
Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut (2006) 2.85
Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun (2007) 2.80
Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol (2006) 2.63
Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol (1998) 2.53
Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med (2009) 2.50
Bacterial diversity and White Plague Disease-associated community changes in the Caribbean coral Montastraea faveolata. ISME J (2009) 2.44
The role of the intestinal microbiota in the development of atopic disorders. Allergy (2007) 2.27
Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol (2007) 2.12
Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine (2000) 1.90
Selective progressive response of soil microbial community to wild oat roots. ISME J (2008) 1.87
Environmental microarray analyses of Antarctic soil microbial communities. ISME J (2008) 1.84
Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med (2007) 1.75
Intestinal microflora of Estonian and Swedish infants. Acta Paediatr (1997) 1.60
Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol (2008) 1.54
Bacterial diversity analysis of Huanglongbing pathogen-infected citrus, using PhyloChip arrays and 16S rRNA gene clone library sequencing. Appl Environ Microbiol (2009) 1.41
Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol (2007) 1.38
Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol (2008) 1.35
Innate immune recognition of the indigenous microbial flora. Mucosal Immunol (2008) 1.33
Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther (2008) 1.18
Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology (2008) 1.15
Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv Food Nutr Res (2009) 1.09
Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol (2008) 1.08
Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr (2008) 1.07
Avian incubation inhibits growth and diversification of bacterial assemblages on eggs. PLoS One (2009) 1.06
Eukaryotic signature proteins of Prosthecobacter dejongeii and Gemmata sp. Wa-1 as revealed by in silico analysis. FEMS Microbiol Lett (2005) 1.03
Changes in oral microbial profiles after periodontal treatment as determined by molecular analysis of 16S rRNA genes. J Med Microbiol (2004) 1.03
Hygiene theory and allergy and asthma prevention. Paediatr Perinat Epidemiol (2007) 1.02
Pandemic of atopic diseases--a lack of microbial exposure in early infancy? Curr Drug Targets Infect Disord (2002) 1.00
Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol (2008) 0.99
Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int J Food Microbiol (2006) 0.98
Microbial manipulation of immune function for asthma prevention: inferences from clinical trials. Proc Am Thorac Soc (2007) 0.97
Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol (2008) 0.91
A longitudinal analysis on the association between antibiotic use, intestinal microflora, and wheezing during the first year of life. J Asthma (2008) 0.88
New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse. J Med Food (2008) 0.88
Probiotics: intestinal gatekeeping, immunomodulation, and hepatic injury. Hepatology (2007) 0.86
Immunomodulatory effects of probiotics in different stages of life. Br J Nutr (2007) 0.85
Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. J Clin Gastroenterol (2008) 0.81
Microecology of the gastrointestinal tract and the immunological status under food allergy. Nahrung (1984) 0.80
Immunomodulation, Part V: probiotics. Neonatal Netw (2007) 0.77
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature (2004) 11.82
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39
Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A (2002) 7.27
Development and validation of a prognostic index for 4-year mortality in older adults. JAMA (2006) 6.79
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01
High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol (2007) 4.81
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A (2007) 4.21
Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis (2007) 4.16
Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol (2002) 3.66
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One (2010) 3.38
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet (2012) 3.20
DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med (2005) 3.06
Ethics and sample size. Am J Epidemiol (2005) 2.88
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med (2007) 2.81
Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med (2004) 2.62
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol (2010) 2.55
Indices for continuity of care: a systematic review of the literature. Med Care Res Rev (2006) 2.54
Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio (2010) 2.53
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med (2013) 2.47
beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med (2005) 2.45
Bacterial diversity and White Plague Disease-associated community changes in the Caribbean coral Montastraea faveolata. ISME J (2009) 2.44
A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS (2010) 2.42
Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol (2010) 2.41
Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med (2003) 2.39
Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med (2002) 2.24
Environmental whole-genome amplification to access microbial populations in contaminated sediments. Appl Environ Microbiol (2006) 2.24
Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2009) 2.15
Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am J Respir Crit Care Med (2008) 2.10
Man's best friend? The effect of pet ownership on house dust microbial communities. J Allergy Clin Immunol (2010) 2.06
Environmental genomics reveals a single-species ecosystem deep within Earth. Science (2008) 1.98
Long-term sustainability of a high-energy, low-diversity crustal biome. Science (2006) 1.97
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis (2011) 1.95
Genome-wide diversity and selective pressure in the human rhinovirus. Virol J (2007) 1.94
National trends in bariatric surgery, 1996-2002. Arch Surg (2006) 1.92
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol (2005) 1.88
A multi-array multi-SNP genotyping algorithm for Affymetrix SNP microarrays. Bioinformatics (2007) 1.88
Rainfall-induced carbon dioxide pulses result from sequential resuscitation of phylogenetically clustered microbial groups. Proc Natl Acad Sci U S A (2012) 1.88
House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci U S A (2013) 1.88
The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol (2007) 1.87
Selective progressive response of soil microbial community to wild oat roots. ISME J (2008) 1.87
Environmental microarray analyses of Antarctic soil microbial communities. ISME J (2008) 1.84
Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. Crit Care Med (2008) 1.82
In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol (2009) 1.78
Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: an RCT. Pediatrics (2013) 1.77
Asthma outcomes: exacerbations. J Allergy Clin Immunol (2012) 1.76
A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med (2012) 1.75
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa. Anesthesiology (2007) 1.73
Do school-based asthma education programs improve self-management and health outcomes? Pediatrics (2009) 1.68
Measuring hospital quality using pediatric readmission and revisit rates. Pediatrics (2013) 1.68
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Differential growth responses of soil bacterial taxa to carbon substrates of varying chemical recalcitrance. Front Microbiol (2011) 1.65
Despite strong seasonal responses, soil microbial consortia are more resilient to long-term changes in rainfall than overlying grassland. ISME J (2009) 1.58
Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J (2010) 1.58
Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS (2004) 1.53
Whole-genome transcriptional analysis of heavy metal stresses in Caulobacter crescentus. J Bacteriol (2005) 1.49
A novel ecological role of the Firmicutes identified in thermophilic microbial fuel cells. ISME J (2008) 1.48
Comfort of general internists and general pediatricians in providing care for young adults with chronic illnesses of childhood. J Gen Intern Med (2008) 1.47
ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am J Respir Crit Care Med (2003) 1.47
Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med (2006) 1.46
Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. J Pediatr Gastroenterol Nutr (2010) 1.45
The relationship between self-rated health and mortality in older black and white Americans. J Am Geriatr Soc (2007) 1.45
Residual-based tree-structured survival analysis. Stat Med (2002) 1.44
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med (2011) 1.43
Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3. Am J Respir Crit Care Med (2015) 1.42
A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol (2010) 1.39
Identifying differentially expressed genes from microarray experiments via statistic synthesis. Bioinformatics (2004) 1.39
The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med (2004) 1.36
Simple, defensible sample sizes based on cost efficiency. Biometrics (2008) 1.32
PCR amplification-independent methods for detection of microbial communities by the high-density microarray PhyloChip. Appl Environ Microbiol (2011) 1.32
Effect of prenatal indoor pet exposure on the trajectory of total IgE levels in early childhood. J Allergy Clin Immunol (2011) 1.32
Direct cellular lysis/protein extraction protocol for soil metaproteomics. J Proteome Res (2010) 1.31
Few amino acid positions in rpoB are associated with most of the rifampin resistance in Mycobacterium tuberculosis. BMC Bioinformatics (2004) 1.31